Evidence map›Paper›PMID 41334296›Full record

ArticleJournal of current ophthalmology

Comparing Lower- and Higher-Order Aberrations: Zywave

Siamak Zarei-Ghanavati, Mojtaba Abrishami, Maryam Hedayati, Elham Bakhtiari

Abstract read
In one paragraph

Article in Journal of current ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Siamak Zarei-GhanavatiEye Research Center, Department of Ophthalmology, Khatam-Al-Anbia Eye Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Mojtaba AbrishamiEye Research Center, Department of Ophthalmology, Khatam-Al-Anbia Eye Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Maryam HedayatiEye Research Center, Department of Ophthalmology, Khatam-Al-Anbia Eye Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Elham BakhtiariEye Research Center, Department of Ophthalmology, Khatam-Al-Anbia Eye Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To assess the agreement between Zywave Methods: In this prospective comparative study, participants aged 20-45 years were examined. Exclusion criteria included previous ocular surgery or trauma, recent contact lens wear, and any ocular or systemic diseases. Each device was operated by an experienced operator who remained blind to the data obtained from the other aberrometer. We compared LOA measurements and the root mean square (RMS) of coma, spherical aberration, and total third- and fourth-order HOAs between the two devices, and the optical zone for measuring HOAs was the same in both the devices. Results: In the study involving 42 eyes of 21 participants (52.4%, female), excellent agreement was observed in LOAs (sphere and cylinder) for both the right and left eyes, with intraclass correlation coefficients of 0.96 and 0.95, respectively, using a 6 mm pupil. In addition, good-to-excellent reliability was reported for the agreement between the two devices in total HOA (t.HOA) and the RMS error of the total aberration, for pupil sizes of 5 mm and 6 mm. However, there was poor agreement between the two devices for third- and fourth-order aberrations in both the pupil sizes. Conclusions: The present study demonstrates agreement between the Zywave

Indexed as

AberrometerHartmann–Shake technologyHigher-order aberrationPeramis CSO aberrometerPyramidal technologyZywave® II wavefront aberrometer

Identifiers

PMID41334296
PMCPMC12668657

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.